Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMost people notice Mounjaro's side effects within the first day or two of their first injection, typically peaking in the 24–72 hours after the dose. The effects are almost always gut-related: nausea, a feeling of fullness, sometimes loose stools. They tend to settle as your body adjusts over the following days. Mounjaro is a prescription-only medicine; a prescriber assesses whether it is suitable for you before treatment begins, and that conversation is the right place to talk through what to expect.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
One of the most widespread misconceptions about Mounjaro is that side effects creep up slowly, becoming worse as the dose increases, and that the first few weeks are a honeymoon period. In practice, the opposite is usually true. The side effects most people experience tend to arrive early and are often at their most noticeable right after the very first injection at the starter dose of 2.5mg.
The reason is pharmacological. Tirzepatide (the active ingredient in Mounjaro) slows how quickly food leaves your stomach. That change is new to your digestive system on day one. Your gut hasn't encountered this medicine before, and the signals it sends back (nausea, fullness, occasional reflux or loose stools) are a sign it is adapting, not a sign something has gone wrong. As described in the NHS patient information on tirzepatide, these effects are common and typically mild to moderate.
For many people, days two and three after the first injection are the worst of it. By the end of the first week or early in the second, things tend to quiet down. The first pen's job is adjustment, not treatment, understanding that reframes the early experience considerably. If you want to explore what the full side-effect picture looks like over time, our Mounjaro side effects overview covers it in detail.
The side-effect pattern tends to repeat, in milder form, with each dose increase. Treatment starts at 2.5mg, and most people titrate upward every four weeks under their prescriber's guidance. Each step up is another adjustment moment. Day one or two after moving from 5mg to 7.5mg, for instance, often brings a brief return of nausea or loose stools, then settles again as the weeks pass.
This matters practically. If someone moves to a higher dose right before a holiday or a busy run of work, they may hit those adjustment days at an inconvenient time. It is worth thinking about the week around a dose change the same way you would plan around any new medicine, not with alarm, but with a little foresight. Our page on when Mounjaro side effects start goes into the early-week pattern in more detail, and there is further reading on how long they take to appear if the timing question is what you came here for.
The MHRA's guidance recommends that any dose increase is supported by clinical review, which is why at nume a prescriber looks at your progress before every repeat, not to create a hurdle, but because that check is genuinely the right moment to discuss how the last dose felt and whether moving up makes sense right now.
The vast majority of Mounjaro's side effects are uncomfortable rather than dangerous. Nausea, constipation, indigestion, burping, or tiredness in the first week of a new dose: these are expected, and the NHS patient information on tirzepatide sets them out clearly. They are not reasons to stop treatment without speaking to your prescriber first.
There are, however, symptoms that need prompt medical attention. In January 2026, the MHRA issued a Drug Safety Update for GLP-1 medicines specifically highlighting acute pancreatitis as an infrequent but serious risk. The symptom to watch for is severe, persistent stomach pain, pain that doesn't ease, that may spread to the back, and that may come with vomiting. That is not something to sit with. Go to A&E or call 999 if the pain is severe; at minimum, call 111 before the next dose.
Other symptoms that warrant medical advice without delay: signs of a serious allergic reaction (swelling of the face or throat, difficulty breathing, a spreading rash), gallbladder pain (sharp, in the upper right abdomen, possibly after eating), or any signs of severe dehydration from persistent vomiting or diarrhoea. If you feel low in mood or have any thoughts of self-harm, stop and speak to someone, your GP, 111, or our aftercare team at contact us.
For anything you are not sure about, the MHRA's Yellow Card scheme lets you report a suspected side effect directly. You do not need a clinician to submit one, patients can do it themselves, and those reports help the MHRA track real-world safety data.
For most people, the acute adjustment symptoms at each dose level last somewhere between a few days and two weeks before fading. That is not a guarantee; some people find certain effects linger longer, and a small number find a particular dose doesn't suit them at all. Both are valid outcomes to discuss with a prescriber. Our page on how long Mounjaro side effects last looks at that question specifically, and if you are wondering whether they stop altogether, our guide on when Mounjaro side effects stop covers what most people can realistically expect as treatment continues.
What tends to reduce with time is the intensity, not necessarily the sensitivity. Some people find they remain more aware of fullness throughout treatment, which is, in part, how the medicine works. The distinction between a side effect and a therapeutic effect can blur: feeling full sooner at a meal is the mechanism. Nausea that makes eating difficult is not.
If you are weighing up Mounjaro as a treatment option, our Mounjaro overview page covers the licensed evidence, how it works, and what the clinical trials found. And if you want to understand the broader landscape of weight-management options, the weight loss treatments page sets out what is currently available through a regulated UK pharmacy like ours. Our prescribers talk through side effects as a standard part of the consultation, check your eligibility to start that conversation.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.